Shixun Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shixun Li has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Yue Ding
Department of Orthopedic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, PR China.
2 shared publications Changchuan Li
Department of Orthopaedic Surgery Sun Yat‐sen Memorial Hospital, Sun Yat‐sen University Guangzhou China
1 shared publication- Changchuan Li
Department of Orthopaedic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People’s Republic of China
1 shared publication Chuangran Wu
Department of Orthopaedic Surgery Sun Yat‐sen Memorial Hospital, Sun Yat‐sen University Guangzhou China
1 shared publication- Guibin Fang
Department of Orthopedics, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
1 shared publication - Junxiong Qiu
Department of Cardiovascular Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
1 shared publication
Latest Publications
- Open Access
- 31 January 2023
- Published by Wiley in Orthopaedic Surgery
- Vol. 15 (3) , 888-898
HUCMSC‐derived Exosomes Suppress the Titanium Particles‐induced Osteolysis in Mice through Inhibiting CCL2 and CCL3
Objective: Wear particles induce inflammation and the further osteolysis around the prosthesis, has been proven to be the main cause of aseptic hip joint loosening. In this research, we aimed to clarify whether human umbilical cord mesenchymal stem cells (HUCMSCs) could inhibit the titanium particles‐induced osteolysis and shed light upon its mechanism.Methods: The expression of chemokine (C‐C motif) ligand 2 (CCL2), chemokine (C‐C motif) ligand 3 (CCL3) and chemokine (C‐C motif) ligand 5 (CCL5) were examinjed in clinical specimens of aseptic hip prosthesis loosening patients. Local injection of lentivirus that knocked down CCL2 or CCL3 in a cranial osteolysis mice model were used to exam the effect of CCL2 and CCL3 on titanium particles‐induced osteolysis in vivo. Transwell assay was used to examine the effect of CCL2 and CCL3 on titanium particles‐induced activation of macrophage in vitro. Furthermore, the therapeutic effect of HUCMSCs, and exosomes from HUCMSCs were also examed in vivo and vitro. Immunohistochemical and real‐time PCR were used to examine the expression of relative pathways. Analysis of variance (ANOVA) and Student–Newman–Keuls post hoc t test were used to analyze the results and determine the statistical significance of the differences.Results: Results showed that titanium particles caused the osteolysis at the mice cranial in vivo and a large number of macrophages that migrated, while local injection of HUCMSCs and exosomes did inhibit the cranial osteolysis and migration. An exosome inhibitor GW4869 significantly increased the osteolysis area in the mice cranium osteolysis model, and increased the number of migrated macrophages. Immunohistochemical results suggested that the expression of CCL2, CCL3 and CD68 in the cranial in Titanium particles mice increased significantly, but was significantly reduced by HUCMSCs or exosomes. HUCMSC and exosomes down‐regulate the expression of CCL3 in vitro and in vivo.Conclusion: HUCMSCs and HUCMSC‐derived exosomes could suppress the titanium particles‐induced osteolysis in mice through inhibiting chemokine (C‐C motif) ligand 2, chemokine (C‐C motif) ligand 3.
- 31 January 2023
- Published by Wiley in Orthopaedic Surgery
- Vol. 15 (3) , 888-898
Open AccessHUCMSC‐derived Exosomes Suppress the Titanium Particles‐induced Osteolysis in Mice through Inhibiting CCL2 and CCL3
Objective: Wear particles induce inflammation and the further osteolysis around the prosthesis, has been proven to be the main cause of aseptic hip joint loosening. In this research, we aimed to clarify whether human umbilical cord mesenchymal stem cells (HUCMSCs) could inhibit the titanium particles‐induced osteolysis and shed light upon its mechanism.Methods: The expression of chemokine (C‐C motif) ligand 2 (CCL2), chemokine (C‐C motif) ligand 3 (CCL3) and chemokine (C‐C motif) ligand 5 (CCL5) were examinjed in clinical specimens of aseptic hip prosthesis loosening patients. Local injection of lentivirus that knocked down CCL2 or CCL3 in a cranial osteolysis mice model were used to exam the effect of CCL2 and CCL3 on titanium particles‐induced osteolysis in vivo. Transwell assay was used to examine the effect of CCL2 and CCL3 on titanium particles‐induced activation of macrophage in vitro. Furthermore, the therapeutic effect of HUCMSCs, and exosomes from HUCMSCs were also examed in vivo and vitro. Immunohistochemical and real‐time PCR were used to examine the expression of relative pathways. Analysis of variance (ANOVA) and Student–Newman–Keuls post hoc t test were used to analyze the results and determine the statistical significance of the differences.Results: Results showed that titanium particles caused the osteolysis at the mice cranial in vivo and a large number of macrophages that migrated, while local injection of HUCMSCs and exosomes did inhibit the cranial osteolysis and migration. An exosome inhibitor GW4869 significantly increased the osteolysis area in the mice cranium osteolysis model, and increased the number of migrated macrophages. Immunohistochemical results suggested that the expression of CCL2, CCL3 and CD68 in the cranial in Titanium particles mice increased significantly, but was significantly reduced by HUCMSCs or exosomes. HUCMSC and exosomes down‐regulate the expression of CCL3 in vitro and in vivo.Conclusion: HUCMSCs and HUCMSC‐derived exosomes could suppress the titanium particles‐induced osteolysis in mice through inhibiting chemokine (C‐C motif) ligand 2, chemokine (C‐C motif) ligand 3.
- Open Access
- 1 May 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (20) , 7018-7032
The USP14–NLRC5 pathway inhibits titanium particle–induced osteolysis in mice by suppressing NF-κB and PI3K/AKT activities
- 1 May 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (20) , 7018-7032
Open AccessThe USP14–NLRC5 pathway inhibits titanium particle–induced osteolysis in mice by suppressing NF-κB and PI3K/AKT activities